View
I've only managed to average down to 100p and I hold 1m - thinking about running for the hills as I can't afford a duster and an SP of 5p. I thought I might get an extra 10p back during drill but that now seems unlikley, and potential upside on discovery seems questionable at best.
This has to be the worst reaction by an SP to 2x farm-ins and the confirmation of commencement of drilling. I note PMO only added 100m in value after discovery. On a like for like basis if PVR come good that would only equate to 250m being added to PVR market cap subject to success – risk reward not great considering this equates to an SP increase of 2.5x on a 10/1 chance.
Interest picking up here since the increased stake in SatoshiPay. This could be an X-bagger.
I spotted the CHC Helicopter flying over West Cork Bantry/Castletownbere this morning at 09:45am approx heading out to the Stena Icemax from Cork Airport. It returned to Cork Airport at 13:20pm approx. Seeing this helicopter filled me with great delight. Hopefully an announcement tomorrow. This is the first CHC flight to Stena Icemax i have spotted so far.
I bought 5,000 shares of Cara Therapeutics, Inc. (NASDAQ:CARA) at $12.32 just minutes ago. The reasoning is mostly technical, as the stock chart is hitting major technical support and is extremely oversold. In addition, at such levels and with promising drug candidates, it becomes a possible buyout target for a big player like Gildead Sciences (GILD) and others. In addition, the company is in the pain relief field. Any drug that is not an opioid can make a company extremely valuable considering the epidemic going on in the United States right now.
Please note, I may sell my Cara Therapeutics, Inc. shares at anytime, depending on market/technical signals. My general upside target is $15.00 near-term.
Gareth Soloway
InTheMoneyStocksI bought 5,000 shares of Cara Therapeutics, Inc. (NASDAQ:CARA) at $12.32 just minutes ago. The reasoning is mostly technical, as the stock chart is hitting major technical support and is extremely oversold. In addition, at such levels and with promising drug candidates, it becomes a possible buyout target for a big player like Gildead Sciences (GILD) and others. In addition, the company is in the pain relief field. Any drug that is not an opioid can make a company extremely valuable considering the epidemic going on in the United States right now.
Please note, I may sell my Cara Therapeutics, Inc. shares at anytime, depending on market/technical signals. My general upside target is $15.00 near-term.
Gareth Soloway
InTheMoneyStocks
Can anyone hazard a guess at NAV per share?
anyone any idea what price will be if it comes up a duster? 5p?
Welcome back Breezy, I hope you had a good holiday. You have missed nothing here but a falling share price. You'd have been better staying in the sunshine. JLP, AFC & RKH are all heading in the wrong direction for me at the moment. I don't need any cash out at the moment and have a little spare to top up too, but not sure I should whilst they're dropping back. CB director buy has had zero effect. Was feeling chipper on the mining license rise back in early March thinking this could be our year, it's not looking that way at the moment. Wishing you well. idg69